Salk School of Science schools and colleges. It is located on the top two floors of the P.S. 40 building on East 20th Street between 1st and 2nd avenue in Manhattan. The school was named for Jonas Salk, developer of the first polio vaccine. Dr. Salk approved the use of his name by NYU before his death in 1995. The school's nontraditional discovery-based learning methodology has been cited as resulting in improved cognitive and reasoning skills in students. Members of the New York medical community work with the school to develop curriculum, and members of the Schools of Medicine and New York University School
The Immune Response Corporation The Immune Response Corporation The Immune Response Corporation (IRC), founded by Jonas Salk and Kevin Kimberlin and based in Carlsbad, California, pioneered immunotherapeutic products. Francis Crick once said about Salk, “Few have made one discovery that has benefited humanity so greatly. Jonas was a man who, right to his last day, was actively in pursuit of another.” That pursuit was The Immune Response Corporation. Kimberlin “asked Salk to become lead scientific advisor for a new biotech company specializing in ‘anti-idiotypes,’ a novel vaccine technology.” Salk called the proposal “liberating.” The management team included CEO Jim Glavin, former CEO of Genetic